Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Epigenomics 1 Year Total Returns (Daily): 245.7% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 245.7% |
| May 03, 2024 | 259.2% |
| May 02, 2024 | 259.2% |
| May 01, 2024 | 260.2% |
| April 30, 2024 | 260.2% |
| April 29, 2024 | 260.2% |
| April 26, 2024 | 260.2% |
| April 25, 2024 | 260.2% |
| April 24, 2024 | 260.2% |
| April 23, 2024 | 260.2% |
| April 22, 2024 | 260.2% |
| April 19, 2024 | 260.2% |
| April 18, 2024 | 260.2% |
| April 17, 2024 | 260.2% |
| April 16, 2024 | 260.2% |
| April 15, 2024 | 260.2% |
| April 12, 2024 | 250.4% |
| April 11, 2024 | 250.4% |
| April 10, 2024 | 250.4% |
| April 09, 2024 | 250.4% |
| April 08, 2024 | 250.4% |
| April 05, 2024 | 250.4% |
| April 04, 2024 | 250.4% |
| April 03, 2024 | 250.4% |
| April 02, 2024 | 250.4% |
| Date | Value |
|---|---|
| April 01, 2024 | 250.4% |
| March 28, 2024 | 250.4% |
| March 27, 2024 | 250.4% |
| March 26, 2024 | 250.4% |
| March 25, 2024 | 250.4% |
| March 22, 2024 | 250.4% |
| March 21, 2024 | 250.4% |
| March 20, 2024 | 87.97% |
| March 19, 2024 | 87.97% |
| March 18, 2024 | 87.97% |
| March 15, 2024 | 87.97% |
| March 14, 2024 | 87.97% |
| March 13, 2024 | 87.97% |
| March 12, 2024 | 87.97% |
| March 11, 2024 | 87.97% |
| March 08, 2024 | 87.97% |
| March 07, 2024 | 87.97% |
| March 06, 2024 | 87.97% |
| March 05, 2024 | 87.97% |
| March 04, 2024 | 87.97% |
| March 01, 2024 | 87.97% |
| February 29, 2024 | 87.97% |
| February 28, 2024 | 87.97% |
| February 27, 2024 | 87.97% |
| February 26, 2024 | 87.97% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.52%
Minimum
Aug 19 2021
260.2%
Maximum
Apr 15 2024
-37.21%
Average
-55.70%
Median
Nov 07 2019
1 Year Total Returns (Daily) Benchmarks
| Affimed NV | -37.66% |
| InflaRx NV | -70.55% |
| MorphoSys AG | 219.4% |
| BioNTech SE | -13.91% |
| Immatics NV | 6.34% |